Shaped by Signals: Leveraging Breast Cancer Nuclear Morphology to Elucidate Regulatory Pathways as Therapeutic Targets
ISEF · 2026 Biomedical and Health Sciences
Overview
Breast cancer (BC) is the most expensive cancer to treat in the United States and a leading cause of cancer-related mortality worldwide. Nuclear enlargement is a well-established histopathologic hallmark of aggressive BC and poor prognosis, however the pathways driving this phenotype and their therapeutic relevance remain incompletely defined. This study leverages BC nuclear morphology to elucidate regulatory pathways driving tumor aggressiveness. Using scRNA-seq data from the Human Tumor Atlas Network (n=10) and non-BC breast tissue from the Genotype-Tissue Expression project (n=9), paired with histology-based nuclear size quantification, a fourfold increase in nuclear size in BC relative to non-BC tissue was observed. High-dimensional weighted gene correlation network analysis revealed dysregulated co-expressed gene sets in BC, reflecting increased transcriptional variability. Linear regression across all genes identified EPDR1 (p<.001, R²=0.94) as one of the strongest and most reproducible nuclear-size-associated BC genes. Cross-dataset gene set comparison and pathway enrichment analyses implicated PI3K/AKT signaling, alongside metabolic pathways, as nuclei-size-associated mechanisms. EPDR1 loss increases intracellular mechanical stress, promoting PI3K/AKT hyperactivation, rapid cell cycling, chromatin decondensation, and nucleomegaly. Additionally, miRNA motif analysis identified miR-615-3p activity (p = 3.57 × 10) as significantly upregulated in BC, targeting the CCGAGCC motif within the EPDR1 3'UTR and likely contributing to its reduced expression. Together, these findings reveal a mechanistic framework linking miR-615-3p-mediated EPDR1 loss to PI3K/AKT-driven nucleomegaly and highlight upstream modulators as promising therapeutic opportunities.
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2025
Single-Cell Analysis Based Identification of Unique Markers and Metastasis Mechanism in Triple-Negative Breast Cancer
ISEF · 2017
Retain CHD7, an Epigenetic Regulator, in the Nucleus to Combat Breast Cancer Metastasis
JSHS · 2020
Deciphering Tumor Heterogeneity in Breast Cancer using Single-Cell Analysis
ISEF · 2024
Targeting of Epichaperome Downregulates HCFC1 Mediated Transcription of Oncogenes: Implications in Breast Cancer Therapy
ISEF · 2015
High Content Analysis and Targeting Cancer-Specific Pathway in Three Dimensional Breast Cancer Tumor Spheroids
ISEF · 2022
Cure of Breast Cancer - Year 5: A Novel Approach to Treating Hormonal Breast Cancer Using Diabetic Medication Through Clinical Database and 3D ex vivo Model
ISEF · 2026
Characterizing Convergent Transcriptomic Impacts of Norepinephrine Across Breast Cancer Grades via Element AVITI-24
ISEF · 2017
Neurotrophin Receptor Isoform Expression Analysis in Breast Invasive Carcinoma: Potential Considerations for Targeted Therapy and Precision Medicine
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair